Voluntary data submission (VDS) pilot application form
Submitted by Anonymous (not verified) on 13 October 2026 - 12:40
Voluntary data submission (VDS) pilot application form
Human medicines European public assessment report (EPAR): Intuniv, guanfacine, Date of authorisation: 17/09/2015, Revision: 15, Status: Authorised
Submitted by Anonymous (not verified) on 13 October 2026 - 12:40
Human medicines European public assessment report (EPAR): Intuniv, guanfacine, Date of authorisation: 17/09/2015, Revision: 15, Status: Authorised
Human medicines European public assessment report (EPAR): Qalsody, tofersen, Date of authorisation: 29/05/2024, Revision: 4, Status: Authorised
Submitted by Anonymous (not verified) on 13 October 2026 - 11:08
Human medicines European public assessment report (EPAR): Qalsody, tofersen, Date of authorisation: 29/05/2024, Revision: 4, Status: Authorised
Article 57 product data
Submitted by Anonymous (not verified) on 13 October 2026 - 11:00
Article 57 product data
HMPC: overview of assessment work - priority list
Submitted by Anonymous (not verified) on 13 October 2026 - 10:40
HMPC: overview of assessment work - priority list
Qualification of novel methodologies for medicine development (QoNM)
Submitted by Anonymous (not verified) on 13 October 2026 - 9:47
Qualification of novel methodologies for medicine development (QoNM)
Qualification of novel methodologies for medicine development: High-level information on CHMP qualification advice
Submitted by Anonymous (not verified) on 13 October 2026 - 9:10
Qualification of novel methodologies for medicine development: High-level information on CHMP qualification advice
Risk management information day 2022, Online, European Medicines Agency, Amsterdam, the Netherlands, 9 December 2022
Submitted by Anonymous (not verified) on 13 October 2026 - 8:12
Risk management information day 2022, Online, European Medicines Agency, Amsterdam, the Netherlands, 9 December 2022
Appendix 1: Acceptable intakes established for N-nitrosamines
Submitted by Anonymous (not verified) on 13 October 2026 - 8:05
Appendix 1: Acceptable intakes established for N-nitrosamines
Human medicines European public assessment report (EPAR): Casgevy, exagamglogene autotemcel, Date of authorisation: 09/02/2024, Revision: 7, Status: Authorised
Submitted by Anonymous (not verified) on 12 October 2026 - 16:00
Human medicines European public assessment report (EPAR): Casgevy, exagamglogene autotemcel, Date of authorisation: 09/02/2024, Revision: 7, Status: Authorised